SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $501 | -94.4% | 385 | -63.3% | 0.00% | – |
| Q3 2021 | $9,000 | +200.0% | 1,050 | +250.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 300 | +115.8% | 0.00% | – |
| Q3 2018 | $2,000 | -94.3% | 139 | -94.4% | 0.00% | – |
| Q2 2018 | $35,000 | -38.6% | 2,487 | -17.1% | 0.00% | – |
| Q1 2018 | $57,000 | -21.9% | 3,000 | -38.1% | 0.00% | -100.0% |
| Q3 2017 | $73,000 | – | 4,845 | +4745.0% | 0.00% | – |
| Q4 2016 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |